Early-Career Members Join NMD4C Working Groups
The NMD4C is happy to announce that six early-career network members have been appointed to leadership roles on three NMD4C working groups: Biobanking, Early-Career, and Knowledge Translation.
The network looks forward to the valuable input and broadened perspective that each member has or will provide to these network activities, and would like to welcome the following early-career members to our working groups:
- Drs. Élise Duchesne and Gerald Pfeffer, who have joined the biobanking working group.
- Drs. Natasha Chang and Cam-Tu Nguyen, who have joined the Early-Career working group.
- Drs. Kessen Patten and Mona Hnaini, who have joined the Knowledge Translation working group.
The NMD4C are committed to empowering the next generation of early-career researchers and clinicians in building successful careers in neuromuscular disease research and clinical practice. Providing early-career leadership opportunities within the network will not only amplify the early-career perspective and help to inform the network’s activities, but also empowers our members to become future leaders in the neuromuscular community.
Other opportunities that the NMD4C provides for early-career members include:
- Sharing blog posts from early-career members
- Research and clinical fellowship funding opportunities
- Webinars and events tailored to early-career audience
If you are an early-career researcher or clinician, please feel free to visit our early-career page or contact James Davis at if you are interested in further engagement with the network.
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.